Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Jul 17, 2020 03:39PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
,,thats just how close Zenith has their finger on the pulse here,,asleep at the wheel,,,,they dont even know that issues will continue to arise around this confusion over similar names. Nor do they take the appropriate steps to safe guard their registered trade name!! But nothing shocks me any more with these companies. Amateur at best, and it shows in share price and respect to existing shareholders. This is my personal opinion.